Excelestar Ventures

Adona Medical is a privately held company focused on developing innovative interventional solutions for heart failure, a condition that affects around 6.5 million patients in the United States and approximately 26 million worldwide. The company's heart failure management system is designed for personalized care, utilizing advanced sensor and shunt technologies to enhance the standard of heart care. By implementing interatrial shunt technology, Adona Medical aims to improve the understanding of a patient's hemodynamic status, allowing healthcare providers to tailor treatments to individual needs and ultimately enhance patient outcomes in managing heart failure.

Brixton Biosciences is a clinical-stage life sciences company focused on developing innovative therapies for chronic and acute pain management. The company aims to address significant unmet needs in this area, which has traditionally relied on systemic medications. Its flagship product, Neural Ice™, is a drug-free injectable treatment designed to induce reversible inhibition of nerves, offering a non-addictive, locally targeted solution. This therapy provides patients with extended pain relief lasting from thirty to sixty days following a single injection, representing a significant advancement over current pain management methods.

Instylla is a Bedford, Massachusetts-based medical equipment supplier specializing in next-generation liquid embolics for interventional radiology. The company focuses on developing innovative embolization products that enhance patient outcomes, particularly in applications such as peripheral hemostasis and interventional oncology. Its flagship product, the Embrace Hydrogel Embolic System, is designed to facilitate controlled, complete, and persistent embolization, providing healthcare professionals with advanced tools for effective treatment in various clinical scenarios.

Sealonix is engaged in the development and commercialization of hemostatic sealants aimed at enhancing surgical procedures. The company is advancing its proprietary biomaterials to create a sealant patch that facilitates rapid hemostasis during abdominopelvic and orthopedic operations. This innovative PramStat patch is designed to bioabsorb within one week of implantation, providing an efficient solution for the healthcare industry in managing bleeding during surgeries.

Datacy is a venture-backed company that specializes in providing a consumer insights data platform aimed at enhancing revenue growth for consumer packaged goods (CPG) in the digital commerce sector. The company empowers consumers by allowing them to control and monetize their personal data while offering businesses a comprehensive understanding of the factors influencing online shopping decisions. Datacy's platform features data collection, secure access, automated organization, and robust privacy measures, enabling clients to efficiently manage and analyze extensive online consumer behavior data. By connecting and interpreting billions of data points, Datacy reveals the intricate patterns and preferences that drive consumer choices, thereby offering valuable insights that facilitate strategic decision-making in digital marketing.

Adona Medical is a privately held company focused on developing innovative interventional solutions for heart failure, a condition that affects around 6.5 million patients in the United States and approximately 26 million worldwide. The company's heart failure management system is designed for personalized care, utilizing advanced sensor and shunt technologies to enhance the standard of heart care. By implementing interatrial shunt technology, Adona Medical aims to improve the understanding of a patient's hemodynamic status, allowing healthcare providers to tailor treatments to individual needs and ultimately enhance patient outcomes in managing heart failure.

Concerto Biosciences specializes in rebuilding microbial communities to enhance human health and environmental sustainability. The company has developed an ultra-high-throughput platform capable of measuring millions of microbial interactions, enabling the mapping of complex inter-species networks that dictate community behavior. This innovation allows Concerto to create "ensembles," which are specific combinations of microbes that collaboratively promote the recovery of damaged microbial ecosystems. By focusing on these microbial ensembles, Concerto aims to address critical global issues across various sectors, including agriculture, healthcare, and industry. The company's pioneering work positions it as a leader in the development of microbial solutions, fundamentally changing how humanity interacts with microbial life.

Chromatic 3D Materials specializes in the development of advanced 3D printing materials, focusing on durable elastomers suitable for manufacturing finished products. The company offers a platform that utilizes reactive extrusion additive manufacturing, allowing for the production of industrial-strength rubber parts. Their proprietary polyurethanes exhibit properties such as flexibility, resilience, and sustainability, catering to the needs of various industries that require adaptable and robust materials. By enabling innovative product designs through customizable material properties, Chromatic 3D Materials positions itself as a leader in the next generation of additive manufacturing solutions.

RoadSync, Inc. is a company that specializes in creating an online payment platform tailored for the logistics industry, among others. Since its founding in 2015 and rebranding from MyLumper Corp. in December 2017, RoadSync has developed a payment portal that facilitates instant receipt generation for carriers, brokers, and drivers, while also providing visibility into billing activities and managing recurring transaction emails. The platform serves a variety of clients, including warehouses, repair and tow services, and logistics providers, enhancing their financial operations by streamlining expense management and enabling secure payment acceptance. This automation not only accelerates payment processes but also improves oversight for both payers and vendors, positioning RoadSync as a key financial solution in the rapidly evolving logistics sector. The company is headquartered in Atlanta, Georgia.

Brixton Biosciences is a clinical-stage life sciences company focused on developing innovative therapies for chronic and acute pain management. The company aims to address significant unmet needs in this area, which has traditionally relied on systemic medications. Its flagship product, Neural Ice™, is a drug-free injectable treatment designed to induce reversible inhibition of nerves, offering a non-addictive, locally targeted solution. This therapy provides patients with extended pain relief lasting from thirty to sixty days following a single injection, representing a significant advancement over current pain management methods.

Instylla is a Bedford, Massachusetts-based medical equipment supplier specializing in next-generation liquid embolics for interventional radiology. The company focuses on developing innovative embolization products that enhance patient outcomes, particularly in applications such as peripheral hemostasis and interventional oncology. Its flagship product, the Embrace Hydrogel Embolic System, is designed to facilitate controlled, complete, and persistent embolization, providing healthcare professionals with advanced tools for effective treatment in various clinical scenarios.

Terecircuits Corporation specializes in the development of materials and processes that facilitate microassembly and mass transfer for displays and advanced electronics. Founded in 2015 and based in Mountain View, California, the company provides a range of advanced polymers, encapsulation materials, and liquid metal interconnects. Its innovations include photo-polymer mass transfer technology specifically designed for MicroLED applications in sectors such as automotive and augmented/virtual reality. Additionally, Terecircuits offers new materials and design frameworks for systems in package manufacturing, targeting the Internet of Things and health technology markets. By serving the display, electronics, and semiconductor industries, Terecircuits enables the creation of low-cost, lightweight, and energy-efficient products, allowing manufacturers to produce IoT devices more efficiently and accurately.

Adona Medical is a privately held company focused on developing innovative interventional solutions for heart failure, a condition that affects around 6.5 million patients in the United States and approximately 26 million worldwide. The company's heart failure management system is designed for personalized care, utilizing advanced sensor and shunt technologies to enhance the standard of heart care. By implementing interatrial shunt technology, Adona Medical aims to improve the understanding of a patient's hemodynamic status, allowing healthcare providers to tailor treatments to individual needs and ultimately enhance patient outcomes in managing heart failure.

Kinnos Inc. is a biotechnology company based in Brooklyn, New York, that specializes in improving disinfection practices through innovative color technology. Founded in 2014, the company manufactures a powdered additive called Highlight, which enhances the visibility of disinfectants, ensuring thorough cleaning and compliance during disinfection processes. Highlight provides real-time color-change feedback, allowing users to see where disinfectants have been applied, which helps prevent disease outbreaks on various surfaces. In addition to Highlight, Kinnos also offers Highlight Wipes, a dispensing machine for wipes, and Highlight Powder, another form of their disinfectant additive. The company's mission is to empower individuals to disinfect with confidence and to enhance public health through effective and visible disinfection.

Kinnos Inc. is a biotechnology company based in Brooklyn, New York, that specializes in improving disinfection practices through innovative color technology. Founded in 2014, the company manufactures a powdered additive called Highlight, which enhances the visibility of disinfectants, ensuring thorough cleaning and compliance during disinfection processes. Highlight provides real-time color-change feedback, allowing users to see where disinfectants have been applied, which helps prevent disease outbreaks on various surfaces. In addition to Highlight, Kinnos also offers Highlight Wipes, a dispensing machine for wipes, and Highlight Powder, another form of their disinfectant additive. The company's mission is to empower individuals to disinfect with confidence and to enhance public health through effective and visible disinfection.

Conformal Medical, Inc. is a medical device company focused on developing innovative solutions to prevent stroke in patients with atrial fibrillation, particularly those with non-valvular atrial fibrillation. Founded in 2016 and based in Nashua, New Hampshire, the company offers CLAAS Technology, which is designed for sealing the left atrial appendage (LAA). This proprietary technology aims to enhance the effectiveness of left atrial appendage closure, addressing a critical need in the management of atrial fibrillation.

Lantos Technologies, Inc. specializes in 3D digital ear scanning technology, which facilitates the design of personalized in-ear devices such as headphones, musicians' monitors, hearing aids, and noise protection solutions. The company's AURA 3D ear scanning system is the only FDA-cleared solution of its kind, providing accurate and minimally invasive mapping of the ear canal. This technology collects multiple data points to create detailed digital maps of the ear, improving the comfort, sound quality, and performance of custom products. By enhancing clinical efficiency and enabling faster turnaround times for custom devices, Lantos Technologies aims to deliver better outcomes for patients and audiologists alike. Founded in 2009 and based in Derry, New Hampshire, the company was previously known as Lantos 2.0 Inc. before rebranding in December 2020.

Diesel Labs, Inc. is a mobile video analytics company based in Boston, Massachusetts, founded in 2016. It specializes in helping marketers convert television ad campaigns into targeted mobile video campaigns by utilizing proprietary technology. Diesel Labs measures audience attention across various entertainment platforms, including social media channels like Twitter, YouTube, TikTok, Facebook, and Instagram. By analyzing engagement data from millions of viewers, the company provides insights that assist media companies in making informed decisions regarding content creation, distribution, and success measurement. Its services streamline cross-channel media planning, enabling clients to efficiently develop mobile campaigns and enhance audience engagement and subscribership without the need for extensive resource allocation.

Altiostar Networks specializes in developing radio area network software aimed at enhancing telecommunications networks. The company focuses on creating solutions that support open interfaces and virtualize baseband units, allowing for the construction of disaggregated, multi-vendor, cloud-native mobile networks. This innovative approach enables mobile network operators to efficiently deploy and expand their LTE networks while reducing costs. Altiostar's experienced team of technology entrepreneurs is dedicated to improving the communications experience through their cutting-edge offerings in the mobile broadband industry.

Anova Data is a cloud-native company that offers an end-to-end analytics framework designed to enhance the strategic capabilities of network operators. Founded in 2015 and based in Westford, Massachusetts, Anova Data's solutions enable operators to shift from reactive to proactive management of their networks. The framework provides out-of-the-box analytics applications that help operators tap into the potential of their network assets across various functions, including marketing, customer care, and service orchestration. By leveraging predictive analytics and dynamic learning, Anova Data's software allows operators to optimize network efficiencies, manage customer experiences, and respond effectively to the increasing volume of subscriber data. This comprehensive approach empowers network operators to capture essential usage records and performance metrics, thus enabling them to maintain control over their networks and support future growth.

SpaceOAR is a privately held medical device company developing in-situ formed, space-filling hydrogels specifically for radiation oncology and cancer surgery indications. Its hydrogel is clinically proven to minimize side effects and protect the quality of life for prostate cancer patients undergoing radiation therapy that enables healthcare providers to minimize urinary, sexual, and bowel side effects of the patients. It was founded in 2007 and is headquartered in Bedford, Massachusetts.

Zettics specializes in mobile analytics and measurement applications, providing operators with comprehensive insights into data usage. The company’s solutions enable operators to enhance subscriber relationships, comply with privacy policies, and monetize data through partnerships with third parties. Zettics' tools allow for the analysis of trends in data usage, enrichment of customer relationship management systems, identification of network abuse, and evaluation of pricing plans. Additionally, they facilitate improved advertising offers, reduction of subscriber churn, and forecasting of network usage growth. With a portfolio of over 60 use cases, Zettics delivers substantial return on investment for operators by offering real-time visibility and analytics across various applications, including video and messaging.

nVision Medical Corporation is a medical device company focused on addressing female health issues, specifically infertility caused by fallopian tube dysfunction and ovarian cancer detection. Founded in 2009 and based in Saratoga, California, nVision Medical develops innovative devices that allow clinicians to assess the health of previously inaccessible areas of the female reproductive tract. The company aims to fill significant gaps in women's health innovation by creating technologies that enhance diagnosis and treatment options. As of 2018, nVision Medical operates as a subsidiary of Boston Scientific Corporation, further leveraging resources to advance its mission in the healthcare sector.

Sera Prognostics, Inc. is a biotechnology company based in Salt Lake City, Utah, focused on developing diagnostic tests that assess a woman's individual risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other pregnancy-related complications. Founded in 2008, Sera aims to improve maternal and neonatal health while addressing the significant economic and healthcare burdens associated with premature birth. The company's proprietary proteomics and bioinformatics platform underpins its pipeline of innovative diagnostic tests, including the PreTRM® Test, which provides physicians with critical information to identify women at higher risk for spontaneous premature delivery. By enabling earlier proactive interventions, Sera seeks to enhance pregnancy care and reduce healthcare delivery costs.